Primary sclerosing cholangitis (PSC) is a progressive liver disease, histologically
characterized by inflammation and fibrosis of the bile ducts, and clinically leading to multi …

Aim The objective of this meta‐analysis was to evaluate the effect of ursodeoxycholic acid
(UDCA) therapy on serum liver function tests. Methods PubMed, Web of Science, Scopus …

The treatment of biliary atresia (BA) is predominantly surgical with firstly an attempt at
restoration of bile flow from the native liver by wide excision of the obstructed, obliterated …

Introduction The complement system, an essential part of the innate immune system, is
involved in various autoimmune diseases. Activation of the complement system by …

Vanishing bile duct syndromes (VBDS) are characterized by progressive destruction of
intrahepatic and sometimes extrahepatic branches of the biliary tree. A common symptom of …

Primary sclerosing cholangitis (PSC) and primary biliary cirrhosis (PBC) are slow
progressive diseases which have been increasing in prevalence. The pathogeneses of PBC …

Background Improved knowledge of the molecular pathophysiology and
immunopathogenesis of cholestatic liver diseases in recent years has led to an increased …

Introduction: Autoimmune liver diseases include autoimmune hepatitis (AIH), primary biliary
cholangitis (PBC), primary sclerosing cholangitis (PSC) and juvenile autoimmune hepatitis …

Урсодезоксихолевая кислота (УДХК)-гидрофильная желчная кислота, которая является
мощным антиоксидантом и в настоящее время используется в качестве панацеи для …

Введение ель монографии—усовершенствовать определение и увеличить
продуктивность терапии холестатических недугов у детей педиатрами, семей ными …